Alpha Teknova (TKNO) Common Equity (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Common Equity came in at $64.9 million in Q1 2026, down 17.4% year-on-year from $78.6 million in Q1 2025, and down 5.6% on a QoQ basis from $68.8 million in Q4 2025.
Alpha Teknova (TKNO) Common Equity (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Common Equity data on file, last reported at $64.9 million in Q1 2026.
- On a quarterly basis, Common Equity fell 17.4% year-over-year to $64.9 million in Q1 2026; TTM through Mar 2026 was $64.9 million, a 17.4% decrease from a year earlier, with the FY2025 full-year figure at $68.8 million, down 16.53% from the prior year.
- Common Equity for Q1 2026 stood at $64.9 million, down from $68.8 million in the prior quarter.
- Over the last five years, Common Equity for TKNO reached as high as $138.5 million in Q1 2022 and fell as low as $64.9 million in Q1 2026.
- Historically, Common Equity has averaged $90.9 million across 5 years, with a median of $86.2 million in 2023.
- Across the five-year window, Common Equity jumped 843.92% in 2022 and slumped 35.41% in 2023, its largest moves.
- Year by year, Common Equity stood at $99.9 million in 2022, then dropped by 9.86% to $90.0 million in 2023, then dropped by 8.49% to $82.4 million in 2024, then slipped by 16.53% to $68.8 million in 2025, then declined by 5.6% to $64.9 million in 2026.
- Per Business Quant data, the three most recent Common Equity figures were $64.9 million in Q1 2026, $68.8 million in Q4 2025, and $72.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.93 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.23 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 3.23 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 47.38 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.90 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 56.13 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 3.41 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.50 Bn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | 64.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.92 Mn |
| Dec 31, 2025 | 68.78 Mn |
| Sep 30, 2025 | 72.65 Mn |
| Jun 30, 2025 | 76.06 Mn |
| Mar 31, 2025 | 78.61 Mn |
| Dec 31, 2024 | 82.39 Mn |
| Sep 30, 2024 | 87.27 Mn |
| Jun 30, 2024 | 78.93 Mn |
| Mar 31, 2024 | 83.38 Mn |
| Dec 31, 2023 | 90.04 Mn |
| Sep 30, 2023 | 99.65 Mn |
| Jun 30, 2023 | 86.21 Mn |
| Mar 31, 2023 | 92.09 Mn |
| Dec 31, 2022 | 99.89 Mn |
| Sep 30, 2022 | 112.00 Mn |
| Jun 30, 2022 | 133.47 Mn |
| Mar 31, 2022 | 138.55 Mn |
| Dec 31, 2021 | 143.20 Mn |
| Sep 30, 2021 | 146.23 Mn |
| Jun 30, 2021 | 149.04 Mn |